Funding for this research was provided by:
Capital Markets Cooperative Research Centre (--, --)
NSW Ministry of Health (--, --)
The University of Sydney (--, --)
HCF Research Foundation (--)
National Health and Medical Research Council (1109626, 1109626)
Article History
Received: 11 June 2019
Accepted: 4 August 2020
First Online: 14 August 2020
Ethics approval and consent to participate
: This study was approved by the NSW Population and Health Services Research Ethics Committee (CI 2015/09/607).
: AGE receives salary support as the HCF Research Foundation Professorial Research Fellow, is a Ministerial appointee to the (Australian) Medicare Benefits Schedule (MBS) Review Taskforce, is a Board Member of the NSW Bureau of Health Information (BHI) and advisor to Cancer Australia. He has consulted on low-value care to Private Healthcare Australia, the Queensland, South Australia and Victoria state health departments, and the Department of Veterans Affairs. TBP receives salary support via a doctoral scholarship from the Capital Markets Cooperative Research Centre-Health Market Quality Program, and a University Postgraduate Award from the University of Sydney, and has received consulting fees from Queensland and Victorian state health departments. TBP is a member of the editorial board of <i>BMC Health Services Research</i>.